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Abstract
Background and Aim—Adipose tissue is the most abundant endocrine tissue in the body,
producing leptin, a hormone important in regulating hunger, and adiponectin, a hormone involved
in insulin sensitivity and inflammation. The aim of this study was to assess the impact of gastric
bypass surgery (GBS) on leptin levels and its relation to adipose tissue expression of adiponectin.
Methods—Omental and subcutaneous adipose tissue and serum were obtained from 40 obese
patients undergoing GBS, 13 patients one-year or more post-GBS, and 16 non-obese individuals
(BMI 20-29). Adiponectin gene expression was measured by quantitative real time PCR and the
gene expression was normalized for the GAPDH gene. Serum leptin and adiponectin were
measured by a high-sensitivity enzymatic assay.
Results—Leptin levels were significantly lower in the post-GBS patients as compared to pre-
GBS patients (19.8±6.7 vs. 59.0±5.1, p=0.0001) and similar to non-obese controls (19.8±6.7 vs.
18.2±4, p=0.8). Univariate analysis showed an inverse correlation between serum leptin levels and
omental adiponectin gene expression (r=-0.32, p=0.01).
Conclusions—Gastric bypass surgery results in resolution of the leptin resistance status that
characterizes obese subjects. We also demonstrated a significant correlation between leptin and
adiponectin. This correlation provides preliminary evidences for studying a potential adiponectin-
leptin cross-talking that may represent one of the physiological pathways responsible for the
regulation of food intake in humans.
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INTRODUCTION
Adipose tissue is the most abundant endocrine tissue in the body, producing several peptides
named adipokines [1]. Among them, the two most important are leptin and adiponectin.
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Leptin is 16 kDa protein encoded by the ob gene in mice (LEP in humans) and secreted by
adipose tissue in circadian pulsatile fashion [2]. Leptin plays a key role in regulating energy
intake and energy expenditure, including appetite and metabolism [2]. Adiponectin is a 247
amino acids protein consisting of four domains, with a molecular weight of 30 kDa that have
insulin-sensitizing, anti-atherogenic, and anti-inflammatory actions [3]. Circulating
concentrations of adiponectin are decreased in subjects with obesity, type 2 diabetes,
hypertension, dyslipidemia, and cardiovascular disease as compared with healthy individuals
[3]. In 2008, Fain and collaborators, using omental adipose tissue explants determined that
adiponectin release is reduced by obesity [4].
Until recently, there was no evidence of interaction between leptin and adiponectin
pathways. In 2004, Minokoshi and collaborators demonstrated in mice that leptin inhibits
AMPK activity in the hypothalamus and thereby reduces food intake [5]. Based on these
findings, Kubota and collaborators investigated in mice the effect of adiponectin on the
leptin-induced suppression of AMPK activity in the hypothalamus [6]. In their study, they
demonstrated that both adiponectin receptors, AdipoR1 and AdipoR2 were found to be
abundantly expressed in the hypothalamus with expression levels comparable to those in the
liver. In situ hybridization revealed that adiponectin and the leptin receptors are localized in
the same region of the hypothalamus. Their work was also fundamental in demonstrating
that after intravenous (IV) infusion of adiponectin, the peptide can cross the
hematoencephalic barrier in the hexamer and trimer forms. Their key finding was the
demonstration that adiponectin and leptin modulate the AMPK phosphorylation in the
hypothalamus [6]. They concluded that the central adiponectin-leptin signaling represents
the physiological pathway by which hypothalamic AMPK activity and food intake are
stimulated under fasting conditions and suppressed by refeeding.
Presently, there are limited evidences of interaction between leptin and adiponectin systems
in humans. The only published study focused on a human disease that is the opposite of
obesity: the anorexia nervosa [7]. In this study, adiponectin levels were inversely correlated
with leptin levels and BMI during in hospital refeeding without reaching statistically
significance [7].
In our study, we hypothesize that the central adiponectin-leptin signaling may represent the
physiological pathway responsible for the anorexia observed after gastric bypass surgery. To
test the hypothesis that this pathway is important in the pathogenesis of human obesity, we
will assess the impact of gastric bypass surgery (GBS) on leptin levels and its relation to
serum and adipose tissue adiponectin levels.
METHODS
After receiving Institutional Review Board approval, 69 study participants were enrolled in
the study. The cohort of participants was divided in three groups: 1) subjects status post-
GBS (with a least 12 months follow up) undergoing an elective abdominal surgical
procedure (e.g. cholecystectomy, abdominal wall hernia repair, and/or abdominoplasty); 2)
subjects with class II and III obesity undergoing GBS, and non-obese (BMI: 20-29) control
subjects requiring an elective abdominal surgery. The study employed the following
exclusion criteria: diagnosis of neoplastic disease, inflammatory bowel disease, acute
cholecystitis, and pregnancy.
During the surgical procedure, immediately after entering the abdominal cavity, two <0.5-
cm3 biopsies of abdominal subcutaneous and intra-abdominal omental fat tissue were
obtained. The tissue samples were washed in PBS solution and then soaked in RNAlater
preservative solution (Qiagen, Courtaboeuf, France) and stored at –80°C. All the samples
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were stored in the same -80°C freezer and then analyzed together. Total RNA was extracted
from the adipose tissue biopsies using the Lipideasy total RNA Mini kit (Qiagen). The
integrity of total RNA was checked by electrophoresis through an agarose gel. Adiponectin
gene expression was studied by quantitative, real time RT-PCR using the specific protocol
for the iCycler iQ Detection System (BioRad ,Hercules, CA, USA) with SYBR green
fluorophore. Reactions were performed in a total volume of 20μL—including 10μL 2×
SYBR Green PCR Master Mix (BioRad ,Hercules, CA, USA), 1μL of each primer at 5μM
concentration, and 1μL of the previously reverse-transcribed cDNA template. The PCR
primer sequence for Adiponectin and GAPDH was chosen based on the sequences available
in GenBank (www.ncbi.nlm.nih.gov/Genbank). Melting curves were used to determine the
specificity of the gene products, which was subsequently confirmed by running the PCR
products on agarose gels. The threshold cycle (CT) value for each reaction, reflecting the
amount of PCR needed to identify a target gene was calculated. Specimens were run in
duplicate and the CT values averaged. GAPDH was used as internal control housekeeping
gene to normalize the PCRs for the amount of RNA added to the reverse transcription
reactions.
A fasting blood sample was also obtained from each subject immediately before the
induction of general anesthesia and immediately spun in a refrigerated (4°C) centrifuge at
3,000 rpm for 10 minutes. The extracted plasma was used for adiponectin and leptin
determinations by high-sensitivity enzyme-linked immunosorbent assay (ELISA).
Statistical Analysis
Comparisons of continuous variables between the groups were completed by unpaired
Student's t tests. Categorical variables were compared using the chi-square test or Fisher's
exact test. Variables that showed a significant univariate correlation were confirmed to be
independent in a multiple stepwise regression model to adjust for potential confounding
factors. The SPSS statistical software program (version 15.0, SPSS, Chicago, USA) was
used for all analyses. All tests were 2-tail. P values of less than 0.05 were considered to
indicate statistical significance.
RESULTS
Abdominal adipose tissues and plasma were obtained from 40 obese subjects undergoing
GB surgery, 16 non-obese subjects, and 13 subjects after gastric bypass at the average
follow-up of 19 months after the procedure.
As shown in Table 1, the three groups showed no significant differences in terms of mean
age. The post-GBS group was characterized by a significant higher percent of female subject
when compared with the non-obese group. Obviously, by study design the post-GBS and the
non-obese groups had a mean BMI significantly lower (P=0.001) than the obese group.
As shown in Figure 1, serum leptin levels were significantly lower (p<0.001) in the post-
GBS patients as compared to the obese patients and similar to the non-obese controls.
Figure 2 depicts total serum adiponectin levels in the three groups. The post-GBS group had
significantly (p=0.004) higher levels of adiponectin than the obese group.
As shown in Figure 3, the adiponectin gene expression in the omental adipose tissues was
significantly different among the three groups. On the contrary, the three groups showed
similar levels of adiponectin gene expression in the subcutaneous adipose tissue samples.
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The correlation plot analysis shown in Figure 4 that includes all the three groups,
demonstrated a significant inverse correlation between serum leptin levels and omental
adiponectin expression (r=-0.32, p=0.01). This univariate correlation was confirmed to be
independent in a multiple stepwise regression model to predict leptin after adjusting for
confounding factors (BMI and age).
Data analysis showed no significant correlation between serum leptin and subcutaneous
adiponectin gene expression (r =-0.20, p=0.1). No significant correlation was also observed
between serum leptin and serum adiponectin (r =-0.14, p=0.2).
DISCUSSION
In the current study, GBS results in resolution of the leptin resistance status that
characterizes obese subjects and up-regulation of the adiponectin gene expression in the
visceral fat. We also demonstrated in the entire cohort of patients enrolled in the study, a
significant correlation between serum leptin and adiponectin gene expression in the visceral
fat. This important correlation provides the basis for further investigations aimed to study
the adiponectin-leptin cross-talking as one of the physiological pathways responsible for the
regulation of food intake in humans.
Adipose tissue is a complex, essential, and highly active metabolic and endocrine organ.
Adipose tissue not only responds to afferent signals from traditional hormone systems and
the central nervous system but also expresses and secretes factors with important endocrine
functions [8]. These factors include leptin and adiponectin. Fain and collaborators have
demonstrated that leptin and adiponectin are mainly secreted by adipocytes whereas other
adipokines are secreted by the stromal vascular fraction of the adipose tissue [9]. Until few
years ago, these two proteins were thought to have no interaction, with only leptin active on
the hypothalamus [10, 11]. A previous study in mice has shown that adiponectin stimulate
fatty acid oxidation and enhance insulin sensitivity through the activation of AMP-activated
protein kinase (AMPK) in the peripheral tissues [12]. However, the effects of adiponectin in
the central nervous system was poorly understood until 2007, when Kubota and
collaborators discovered that adiponectin stimulates AMPK in the hypothalamus and
increases food intake [6]. Before this pivotal study, adiponectin was not thought to have a
key role in regulating energy intake and energy expenditure. Because leptin has been
reported to inhibit AMPK activity in the hypothalamus and to thereby suppress food intake
[5], Kubota et al also investigated the effect of adiponectin on the leptin-induced
suppression of AMPK activity in the hypothalamus [6]. Their key finding was that the
leptin-induced AMPK phosphorylation suppression in the hypothalamus was significantly
reversed by IV injection of adiponectin [6]. Recently, these results were also validated by a
study from Coope and collaborators where intracerebroventricular injection of recombinant
rat adiponectin promoted anorexigenic condition in rats with a 40% reduction in food intake
and activates signal transduction through the classical insulin and leptin signaling pathways
[13].
Preliminary evidence of interaction between the adiponectin and leptin systems was also
provided by studying serum adiponectin and leptin levels in subjects with anorexia nervosa
[7]. In this study serum adiponectin levels were inversely correlated with leptin levels and
BMI during in hospital refeeding. This finding corroborates the results of a previous animal
study suggesting that adiponectin might have a role in maintaining energy homeostasis
under energy shortage conditions [14].
Several studies have shown resolution of the leptin-resistance status after bariatric surgery
procedures [15-19]. Serum adiponectin is also well known to increase significantly after
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weight loss induced by bariatric surgery [20-22]. On the contrary, very few studies have
focused on the adiponectin gene expression in adipose tissue before and after bariatric
surgery [20, 23]. However, in all these studies samples were taken only from the
subcutaneous fat depot. Our study was innovative in that it included a determination of
adiponectin gene expression in the visceral fat before and after GBS and more important, we
were able to demonstrate for the first time in humans a significant correlation between
omental adiponectin and serum leptin. Our current findings support the hypothesis that high
levels of circulating adiponectin combined with low level of leptin may be responsible for
the anorexia observed after GBS [24]. Further studies using a rodent model of GBS are
needed to confirm that increased postoperative adiponectin levels enhances AMPK activity
in the arcuate hypothalamus via its receptor to regulate food intake.
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Serum leptin levels in the three groups
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Serum adiponectin levels in the three groups
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Adiponectin gene expression in subcutaneous and omental fat depots
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Correlation plot between serum leptin and omental adiponectin.
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